恆銘達(002947.SZ): 定增決議有效期及授權期限延長12個月
格隆匯7月8日丨恆銘達(002947.SZ)公佈,2021年7月8日,公司召開第二屆董事會第十六次會議及第二屆監事會第十二次會議,審議通過《關於延長公司非公開發行股票股東大會決議有效期的議案》及《關於提請股東大會延長授權董事會辦理公司本次非公開發行股票相關事宜有效期的議案》,同意將該次非公開發行股票的股東大會決議的有效期及股東大會授權董事會辦理該次公司非公開發行股票相關事宜的有效期延長至中國證監會關於公司該次非公開發行核准批文規定的12個月有效期截止日。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.